Addressing the Challenges of CNS Drug Delivery
Diseases of the central nervous system (CNS) represent one of the most complex groups of conditions in the world. Developing therapeutics that treat diseases of the brain especially has been an uphill struggle in terms of optimising drug delivery systems....
5 years agoAddressing the Challenges of CNS Drug Delivery
Diseases of the central nervous system (CNS) represent one of the most complex groups of conditions in the world. Developing therapeutics that treat diseases of the brain especially has been an uphill struggle in terms of optimising drug delivery systems....
5 years ago
The Latest Advancements in Immuno-oncology: Checkpoint Inhibitors
Until now, patients with advanced cervical cancer had relatively low survival rates. The recent approval of Keytruda, a PD-1/PD-L1 checkpoint inhibitor, is the latest breakthrough for cervical cancer immunotherapy. The positive outcome from Merck & Co’s clinical trial now offers...
5 years agoThe Latest Advancements in Immuno-oncology: Checkpoint Inhibitors
Until now, patients with advanced cervical cancer had relatively low survival rates. The recent approval of Keytruda, a PD-1/PD-L1 checkpoint inhibitor, is the latest breakthrough for cervical cancer immunotherapy. The positive outcome from Merck & Co’s clinical trial now offers...
5 years ago
Building a FAIR Culture in Pharma
The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...
5 years agoBuilding a FAIR Culture in Pharma
The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...
5 years ago
Utilising Machine Learning in Drug Discovery: Opportunities and Challenges
From artificial neural networks to predictive modelling, artificial intelligence (AI) is making its mark in the pharmaceutical industry. The ever-increasing cost of development, shorter timelines and rise in demand has seen the industry reach out to AI to help bring...
5 years agoUtilising Machine Learning in Drug Discovery: Opportunities and Challenges
From artificial neural networks to predictive modelling, artificial intelligence (AI) is making its mark in the pharmaceutical industry. The ever-increasing cost of development, shorter timelines and rise in demand has seen the industry reach out to AI to help bring...
5 years ago
Emisphere’s Stockholders Sue Over Novo Nordisk Purchase
For daily articles on the latest pharma trends and innovations, as well as interviews with leading experts and in-depth industry White Papers, subscribe to PharmaFeatures.com. A trio of lawsuits are being levelled at Emisphere Technologies over its recent sale to Novo...
5 years agoEmisphere’s Stockholders Sue Over Novo Nordisk Purchase
For daily articles on the latest pharma trends and innovations, as well as interviews with leading experts and in-depth industry White Papers, subscribe to PharmaFeatures.com. A trio of lawsuits are being levelled at Emisphere Technologies over its recent sale to Novo...
5 years ago
The Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu
Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...
5 years agoThe Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu
Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...
5 years agoInterested?
Reserve your space
